New acne gel shows promise in Large-Scale trial
NCT ID NCT07384195
First seen Feb 03, 2026 · Last updated May 06, 2026 · Updated 7 times
Summary
This study tests a new gel applied once daily for 12 weeks to reduce acne lesions on the face and trunk. About 400 people with acne vulgaris will either receive the active gel or a placebo. Researchers will measure changes in pimple counts and skin clearness at the end of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Policlinico Universitario Tor Vergata
Roma, RM, 00133, Italy
-
Azienda Ospedaliera Universitaria Federico II Di Napoli
Naples, 80131, Italy
-
Azienda Ospedaliero Universitaria Delle Marche
Ancona, AN, 60126, Italy
-
Azienda Ospedaliero Universitaria Parma
Parma, PR, 43126, Italy
-
Azienda USL Toscana Centro
Florence, FI, 50125, Italy
-
Centrum Zdrowia Dziecka I Rodziny Im. Jana Pawla II W Sosnowcu Sp. z o.o.
Sosnowiec, Poland
-
DERMAPOLIS Medical Dermatology Center dr n.med. Edyta Gebska
Chorzów, Poland
-
Dermed Centrum Medyczne Sp. z o.o.
Lodz, Poland
-
EMC Instytut Medyczny S.A.
Wroclaw, Poland
-
Fondazione IRCCS Policlinico San Matteo
Pavia, PV, 27100, Italy
-
Futuremeds Spain S.L.
Madrid, 28003, Spain
-
Futuremeds Spain S.L.
Seville, 41012, Spain
-
Hospital Quironsalud Infanta Luisa
Seville, 41010, Spain
-
Hospital Universitario Hm Sanchinarro
Madrid, Spain
-
Hospital Universitario Regional De Malaga
Málaga, 29010, Spain
-
Hospital Universitario Virgen De La Victoria
Málaga, 29010, Spain
-
I.F.O. Istituti Fisioterapici Ospitalieri
Roma, RM, 00144, Italy
-
IRCCS Ospedale Policlinico San Martino
Genova, GE, 16132, Italy
-
Klinika Ambroziak Sp. z o.o.
Warsaw, Poland
-
Labderm Essence Sp. z o.o.
Ożarowice, Poland
-
Lukmed 2 Sp. z o.o.
Siedlce, Poland
-
Provita Sp. z o.o.
Katowice, Poland
-
Royalderm Agnieszka Nawrocka
Warsaw, Poland
-
Sant Joan De Deu Barcelona Hospital
Esplugues de Llobregat, 08950, Spain
-
Silmedic Sp. z o.o.
Katowice, Poland
-
St-Inspire Sp. z o.o.
Mikołów, Poland
-
Twoja Przychodnia Nowosolskie Centrum Medyczne Sp. z o.o.
Nowa Sól, Poland
-
Twoja Przychodnia Poznanskie Centrum Medyczne Sp. z o.o.
Poznan, Poland
-
Vitamed Galaj I Cichomski Sp. j.
Bydgoszcz, Poland
Conditions
Explore the condition pages connected to this study.